Female genital tissue not foolproof barrier to HIV sexual transmission

December 16, 2008

Contrary to a widely-held assumption about heterosexual transmission of HIV, the normal mucosal lining of the female genital tract is not a foolproof barrier to viral penetration, scientists at the Northwestern University School of Medicine in Chicago report at the American Society for Cell Biology (ASCB) 48th Annual Meeting, Dec. 13-17, 2008 in San Francisco.

"This is an unexpected and important result," says Thomas Hope of Northwestern, "because it is generally believed that the squamous epithelium of the female genital tract is an efficient barrier to viral penetration."

By labeling individual HIV virons with photoactivated fluorescent tags, Hope and his Northwestern colleagues were able to view the virus as it penetrated the squamous epithelium, the outermost most lining of the female genital tract.

The studies were conducted with lab cultures of human tissue obtained during hysterectomies and in tissue from rhesus macaque monkeys.

The researchers determined that HIV penetrated the genital skin barrier primarily by moving quickly, in just four hours, between skin cells to reach 50 microns beneath the skin, the depths in the tissue at which the immune cells targeted by HIV are located.

HIV penetration was more common in the outermost superficial squamous epithelial layers and likely occurred during the normal turnover and shedding of skin cells. Then the skin cells are no longer tightly bound together, so water and HIV can easily enter.

Until now, scientists have had minimal data about how the virus penetrates epithelial barriers to find its specific immune cell targets such as CD4 positive T cells, macrophages, Langerhans cells, and dendritic cells.

Hope points out that new therapeutics or prevention strategies to block the entry of HIV through the superficial layers protecting the female genital tract are urgently needed.
-end-
The latest data from the U.S. Centers for Disease Control show that 31 percent of total new HIV infections each year can be traced to high-risk heterosexual contact.

For more information:

Contact John Fleischman, ASCB science writer, jfleischman@ascb.org, (513) 929-4635, (513) 706-0212,
or
Cathy Yarbrough, freelance ASCB annual meeting media coordinator, cyarbrough@ascb.org, (858) 243-1814.

or

Thomas Hope
Department of Cell and Molecular Biology
Northwestern University Medical School
Chicago, IL 60611
thope@northwestern.edu
(312) 503-1360

Author presents his paper, "Analysis of the Interaction of HIV with Female Genital Tract Tissue as a Model to Understand Sexual Transmission," on Tuesday, Dec.16 at 3:45 p.m., during Minisymposium 20, Cellular Response to Infectious Agents, in Room 104, Moscone Center

Authors: A. Trull, S. McCoombe, M. McRaven, Northwestern University Medical School, Chicago, IL; R.S. Veazey, Tulane University, New Orleans, LA; T. Hope, Northwestern University Medical School.

American Society for Cell Biology

Related HIV Articles from Brightsurf:

BEAT-HIV Delaney collaboratory issues recommendations measuring persistent HIV reservoirs
Spearheaded by Wistar scientists, top worldwide HIV researchers from the BEAT-HIV Martin Delaney Collaboratory to Cure HIV-1 Infection by Combination Immunotherapy (BEAT-HIV Collaboratory) compiled the first comprehensive set of recommendations on how to best measure the size of persistent HIV reservoirs during cure-directed clinical studies.

The Lancet HIV: Study suggests a second patient has been cured of HIV
A study of the second HIV patient to undergo successful stem cell transplantation from donors with a HIV-resistant gene, finds that there was no active viral infection in the patient's blood 30 months after they stopped anti-retroviral therapy, according to a case report published in The Lancet HIV journal and presented at CROI (Conference on Retroviruses and Opportunistic Infections).

Children with HIV score below HIV-negative peers in cognitive, motor function tests
Children who acquired HIV in utero or during birth or breastfeeding did not perform as well as their peers who do not have HIV on tests measuring cognitive ability, motor function and attention, according to a report published online today in Clinical Infectious Diseases.

Efforts to end the HIV epidemic must not ignore people already living with HIV
Efforts to prevent new HIV transmissions in the US must be accompanied by addressing HIV-associated comorbidities to improve the health of people already living with HIV, NIH experts assert in the third of a series of JAMA commentaries.

The Lancet HIV: Severe anti-LGBT legislations associated with lower testing and awareness of HIV in African countries
This first systematic review to investigate HIV testing, treatment and viral suppression in men who have sex with men in Africa finds that among the most recent studies (conducted after 2011) only half of men have been tested for HIV in the past 12 months.

The Lancet HIV: Tenfold increase in number of adolescents on HIV treatment in South Africa since 2010, but many still untreated
A new study of more than 700,000 one to 19-year olds being treated for HIV infection suggests a ten-fold increase in the number of adolescents aged 15 to 19 receiving HIV treatment in South Africa, according to results published in The Lancet HIV journal.

Starting HIV treatment in ERs may be key to ending HIV spread worldwide
In a follow-up study conducted in South Africa, Johns Hopkins Medicine researchers say they have evidence that hospital emergency departments (EDs) worldwide may be key strategic settings for curbing the spread of HIV infections in hard-to-reach populations if the EDs jump-start treatment and case management as well as diagnosis of the disease.

NIH HIV experts prioritize research to achieve sustained ART-free HIV remission
Achieving sustained remission of HIV without life-long antiretroviral therapy (ART) is a top HIV research priority, according to a new commentary in JAMA by experts at the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health.

The Lancet HIV: PrEP implementation is associated with a rapid decline in new HIV infections
Study from Australia is the first to evaluate a population-level roll-out of pre-exposure prophylaxis (PrEP) in men who have sex with men.

Researchers date 'hibernating' HIV strains, advancing BC's leadership in HIV cure research
Researchers have developed a novel way for dating 'hibernating' HIV strains, in an advancement for HIV cure research.

Read More: HIV News and HIV Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.